2030 年までのヨーロッパの抗体発見市場の予測 - 地域分析 - 抗体の種類 (モノクローナル抗体、ポリクローナル抗体、その他)、性質 (ヒトおよびヒト化、キメラ、マウス)、サービス (ファージディスプレイ、ハイブリドーマ、トランスジェニック動物、単一細胞、酵母ディスプレイ)、およびエンドユーザー (製薬およびバイオテクノロジー企業、研究機関、その他) 別

BMIRE00030736 | Pages: 94 | Biotechnology | Sep 2024 | Type: Regional | Status: Published
ヨーロッパの抗体発見市場は、2022年に8,24,441.11百万米ドルと評価され、2030年までに13,29,481.60百万米ドルに達すると予想されています。2022年から2030年にかけて6.2%のCAGRを記録すると推定されています。

がんの発生率上昇がヨーロッパの抗体発見市場を牽引

2020年に発表された世界がん観測所(GLOBOCAN)の推定によると、世界中で1,930万件のがん症例がありました。2030年1月までに、がん生存者の人口は2,210万人に達すると推定されており、これは主に人口の高齢化に関連している可能性があります。肺がん、乳房がん、大腸がん、前立腺がん、乳がんは、最も一般的に報告されているがんの種類です。がんの発生率の上昇は、世界中で懸念を引き起こしています。以下は、2020 年に世界中で報告された一般的な癌症例のリストです。

2020 年の世界中の新規癌症例

Sr. No.

がんの種類

症例数(百万)

1



1.09

2

皮膚(非黒色腫)

1.2

3

前立腺

1.41

4

結腸と直腸

1.93

5



2.21

6

乳房

2.26

出典:世界保健機関、2020年2月

がんは現在、不健康な食習慣を持つ人や運動をあまりしない人によく見られる生活習慣病です。アルコールやタバコを頻繁に摂取すると、がんを発症するリスクが高まります。低所得国および中所得国における慢性感染症は、がんリスク要因をさらに悪化させる可能性があります。がんの発生率の急増は、革新的ながん治療の必要性を示しています。モノクローナル抗体は、免疫系の自然な能力を高めてがん細胞の活動を抑制し、がん細胞を排除する有望な標的抗がん剤のクラスです。抗体薬物複合体 (ADC) も、がん治療において有望な結果を示しています。さらに、現代のバイオテクノロジーの進歩により、研究者や企業は適切に設計された新しい抗体を提供できるようになり、さまざまな種類のがんの治療を成功させる道が開かれています。このように、さまざまな種類のがんの発生率が急増していることが、抗体発見市場の成長を後押ししています。

ヨーロッパの抗体発見市場の概要

ヨーロッパの抗体発見市場は、ドイツ、イギリス、フランス、イタリア、スペイン、その他のヨーロッパに分かれています。この地域は、世界市場の大きなシェアを占めています。今後数年間、R&Dアプリケーション、がん治療、免疫疾患管理におけるモノクローナル抗体の使用が急増しているため、堅調な成長率を記録すると予想されています。さらに、患者データ管理システムの必要性の高まり、慢性疾患の蔓延、抗体サービスの実装に関する政府の取り組みにより、フランス、イタリア、スペインなどの国で抗体発見市場に成長の機会がもたらされると予想されています。

ヨーロッパの抗体発見市場の収益と2030年までの予測(10億米ドル)

ヨーロッパの抗体発見市場のセグメンテーション

ヨーロッパの抗体発見市場は、抗体の種類、性質、サービス、エンドユーザー、国に分類されています。

抗体の種類に基づいて、ヨーロッパの抗体発見市場は、モノクローナル抗体、ポリクローナル抗体、その他に分類されています。モノクローナル抗体セグメントは、2022年にヨーロッパで最大の抗体発見市場シェアを占めました。

性質上、ヨーロッパの抗体発見市場は、ヒトおよびヒト化、キメラ、マウスに分類されます。 ヒトおよびヒト化セグメントは、2022年にヨーロッパで最大の抗体発見市場シェアを占めました。

サービス別に見ると、ヨーロッパの抗体発見市場は、ファージディスプレイ、ハイブリドーマ、トランスジェニック動物、単一細胞、酵母ディスプレイに分かれています。 ファージディスプレイセグメントは、2022年にヨーロッパで最大の抗体発見市場シェアを占めました。

エンドユーザーに基づいて、ヨーロッパの抗体発見市場は、製薬およびバイオテクノロジー企業、研究室、その他に分類されます。 製薬およびバイオテクノロジー企業セグメントは、2022年にヨーロッパで最大の抗体発見市場シェアを占めました。

国に基づいて、ヨーロッパの抗体発見市場は、ドイツ、イギリス、フランス、イタリア、スペイン、その他のヨーロッパに分類されます。 2022年、ヨーロッパの抗体発見市場シェアはドイツが独占しました。

ヨーロッパの抗体発見市場で事業を展開している大手企業には、Charles River Laboratories International Inc、Creative Biolabs Inc、Evotec SE、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp、Biocytogen Pharmaceuticals Beijing Co Ltd. などがあります。

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Antibody Discovery Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Investments in Research & Development

4.1.2 Rising Incidence of Cancer

4.2 Market Restraints

4.2.1 High Cost of Production

4.3 Market Opportunities

4.3.1 Proliferation of Biotechnology Industry in Developing Regions

4.4 Future Trends

4.4.1 Developments for Custom Antibodies

4.5 Impact of Drivers and Restraints:

5. Antibody Discovery Market - Europe Market Analysis

5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. Europe Antibody Discovery Market Analysis - by Antibody Type

6.1 Overview

6.2 Monoclonal Antibodies

6.2.1 Overview

6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Polyclonal Antibodies

6.3.1 Overview

6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Antibody Discovery Market Analysis - by Nature

7.1 Overview

7.2 Human and Humanized

7.2.1 Overview

7.2.2 Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Chimeric

7.3.1 Overview

7.3.2 Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Murine

7.4.1 Overview

7.4.2 Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Antibody Discovery Market Analysis - by Services

8.1 Overview

8.2 Phage Display

8.2.1 Overview

8.2.2 Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Hybridoma

8.3.1 Overview

8.3.2 Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Transgenic Animal

8.4.1 Overview

8.4.2 Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Yeast Display

8.5.1 Overview

8.5.2 Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Single Cell

8.6.1 Overview

8.6.2 Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Antibody Discovery Market Analysis - by End User

9.1 Overview

9.2 Pharmaceutical and Biotechnology Companies

9.2.1 Overview

9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Research Laboratories

9.3.1 Overview

9.3.2 Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Others

9.4.1 Overview

9.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Antibody Discovery Market - Country Analysis

10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030

10.1.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country

10.1.1.1 UK

10.1.1.1.1 Overview

10.1.1.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature

10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services

10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User

10.1.1.2 Germany

10.1.1.2.1 Overview

10.1.1.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature

10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services

10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User

10.1.1.3 France

10.1.1.3.1 Overview

10.1.1.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature

10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services

10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User

10.1.1.4 Italy

10.1.1.4.1 Overview

10.1.1.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature

10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services

10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User

10.1.1.5 Spain

10.1.1.5.1 Overview

10.1.1.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature

10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services

10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User

10.1.1.6 Rest of Europe

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature

10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services

10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Antibody Discovery Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Charles River Laboratories International Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Creative Biolabs Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Evotec SE

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Sartorius AG

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Aragen Life Sciences Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Twist Bioscience Corp

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Biocytogen Pharmaceuticals Beijing Co Ltd

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

 

List of Tables

Table 1. Europe Antibody Discovery Market Segmentation

Table 2. New Cancer Cases Worldwide, in 2020

Table 3. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 4. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 5. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 6. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 7. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 8. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 9. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 10. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 11. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 12. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 13. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 14. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 15. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 16. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 17. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 18. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 19. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 20. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 21. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 22. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 23. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 24. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 25. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 26. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market

Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market

Table 29. Glossary of Terms, Antibody Discovery Market

 

List of Figures

Figure 1. Europe Antibody Discovery Market Segmentation, by Country

Figure 2. Europe Antibody Discovery Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Antibody Discovery Market Revenue (US$ Million), 2020 - 2030

Figure 5. Europe Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)

Figure 6. Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Europe Antibody Discovery Market Share (%) - by Nature (2022 and 2030)

Figure 10. Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Europe Antibody Discovery Market Share (%) - by Services (2022 and 2030)

Figure 14. Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Europe Antibody Discovery Market Share (%) - by End User (2022 and 2030)

Figure 20. Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)

Figure 24. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 26. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 27. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 29. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 30. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 31. Growth Strategies in the Antibody Discovery Market

  1. Charles River Laboratories International Inc
  2. Creative Biolabs Inc
  3. Evotec SE
  4. Sartorius AG
  5. Aragen Life Sciences Ltd
  6. Twist Bioscience Corp
  7. Biocytogen Pharmaceuticals Beijing Co Ltd
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe antibody discovery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe antibody discovery market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440